Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer.

Authors

Nausharwan Butt, Thomas Jefferson UniversityFollow
Farooq H Sheikh, Thomas Jefferson UniversityFollow

Document Type

Article

Publication Date

1-1-2023

Comments

This article is the author’s final published version in Methodist DeBakey cardiovascular journal, Volume 19, Issue 1, January 2023, Pages 15 - 19.

The published version is available at https://doi.org/10.14797/mdcvj.1115. Copyright © Butt and Sheikh.

Abstract

The HeartMate 3 left ventricular assist device possesses the unique feature of having its electronics and software located within the housing of the pump, which may predispose it to malfunction from radiation exposure during cancer treatment. We investigated this association in a case series of two patients at our institution.

Recommended Citation

Butt, Nausharwan and Sheikh, Farooq H, "Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer." (2023). Division of Cardiology Faculty Papers. Paper 114.
https://jdc.jefferson.edu/cardiologyfp/114

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

Language

English

PubMed ID

36742441